Insights into Cancer Stem Cells
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 2958
Special Issue Editor
Interests: chemokine receptors; chemotaxis; cap-dependent mRNA translation in cancer; eukaryotic translation initiation factors, eIF4A1, metastasis; breast cancer; pancreatic cancer; precision medicine/targeted therapy; small molecule inhibitors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer stem cells (CSCs) or cancer stem-like cells (CSLCs) comprise a small percentage of cells (2–5%) in a given tumor type. Despite this fact, they play a vital role in minimal residual disease and subsequent relapse with associated chemoresistance. Cancer stemness has been a challenge in clinical settings to overcome therapy failure. Simultaneous elimination of CSCs or CSLCs and bulk tumor cells is critical to win the chemotherapy battle.
For this Special Issue of Cancers, we welcome original research and review articles that provide an overview of the most recent advances and future challenges involving CSCs or CSLCs: (1) novel and vulnerable molecular targets; (2) novel autocrine pathways and paracrine mechanisms between CSCs and stromal elements such as immune cells; (3) development of novel therapies including immunotherapies; (4) drug resistance mechanisms; (5) mechanisms by which pluripotency is regulated and maintained; (6) CSC niche; (7) novel and emerging technologies to study cancer stemness; (8) epigenetic influences on CSC/CSCLs.
Dr. Dayanidhi Raman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
